Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
Jun Young Kim, Dong Hyun Sinn, Geum-Youn Gwak, Gyu-Seong Choi, Aldosri Meshal Saleh, Jae-Won Joh, Sung Ki Cho, Sung Wook Shin, Keumhee Chough Carriere, Joong Hyun Ahn, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Clin Mol Hepatol. 2016;22(2):250-258.   Published online 2016 Jun 25     DOI: https://doi.org/10.3350/cmh.2016.0015
Citations to this article as recorded by Crossref logo
The Clinical Value of Postoperative Transarterial Chemoembolization for Resectable Patients with Intermediate Hepatocellular Carcinoma After Radical Hepatectomy: a Propensity Score-Matching Study
Lei Wang, Nanping Lin, Kongying Lin, Chunhong Xiao, Ren Wang, Jingbo Chen, Weiping Zhou, Jingfeng Liu
Journal of Gastrointestinal Surgery.2021; 25(5): 1172.     CrossRef
Direct-Acting Antivirals Improve Treatment Outcomes in Patients with Hepatitis C Virus-Related Hepatocellular Carcinoma Treated with Transarterial Chemoembolization: A Nationwide, Multi-center, Retrospective Cohort Study
Hye Kyung Hyun, Eun Ju Cho, Soo Young Park, Young Mi Hong, Soon Sun Kim, Hwi Young Kim, Nae-Yun Heo, Jung Gil Park, Dong Hyun Sinn, Wonseok Kang, Song Won Jeong, Myeong Jun Song, Hana Park, Danbi Lee, Yong Sun Lee, Sung Bum Cho, Chan Sik An, Hyung Jin Rhe
Digestive Diseases and Sciences.2021; 66(7): 2427.     CrossRef
Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma
Xiang-Ke Niu, Xiao-Feng He
World Journal of Gastroenterology.2021; 27(2): 189.     CrossRef
Prognostic Value of Alpha-Fetoprotein in Patients Who Achieve a Complete Response to Transarterial Chemoembolization for Hepatocellular Carcinoma
Jae Seung Lee, Young Eun Chon, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Wonseok Kang, Moon Seok Choi, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Hwi Young Kim, Tae Hun Kim, Kwon Yoo,
Yonsei Medical Journal.2021; 62(1): 12.     CrossRef
Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization
Yuna Kim, Jae Seung Lee, Hye Won Lee, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Seung Up Kim
Current Oncology.2021; 28(1): 965.     CrossRef
Prediction of Patient Survival Following Hepatic Resection in Early-Stage Hepatocellular Carcinoma with Indexed Ratios of Aspartate Aminotransferase to Platelets: A Retrospective Cohort Study
Jian Huang, Yun Yang, Yong Xia, Fu-Chen Liu, Lei Liu, Peng Zhu, Sheng-Xian Yuan, Fang-Ming Gu, Si-Yuan Fu, Wei-Ping Zhou, Hui Liu, Bei-Ge Jiang, Ze-Ya Pan
Cancer Management and Research.2021; Volume 13: 1733.     CrossRef
Efficacy of Combined Therapy with Drug-Eluting Beads-Transcatheter Arterial Chemoembolization Followed by Conventional Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Multi-Center Study
Asahiro Morishita, Joji Tani, Takako Nomura, Kei Takuma, Mai Nakahara, Kyoko Oura, Tomoko Tadokoro, Koji Fujita, Tingting Shi, Hiroki Yamana, Takanori Matsui, Tadayuki Takata, Takayuki Sanomura, Yoshihiro Nishiyama, Takashi Himoto, Tetsu Tomonari, Akio Mo
Cancers.2021; 13(18): 4605.     CrossRef
An observational study on long‐term renal outcome in patients with chronic hepatitis B treated with tenofovir disoproxil fumarate
Tae Seop Lim, Jae Seung Lee, Beom Kyung Kim, Hye Won Lee, Mi Young Jeon, Seung Up Kim, Jun Yong Park, Do Young Kim, Kwang‐Hyub Han, Sang Hoon Ahn
Journal of Viral Hepatitis.2020; 27(3): 316.     CrossRef
Transarterial strategies for the treatment of unresectable hepatocellular carcinoma: A systematic review
Biao Yang, Jie Liang, ZiYu Qu, FangYun Yang, ZhengYin Liao, HongFeng Gou, Gianfranco D. Alpini
PLOS ONE.2020; 15(2): e0227475.     CrossRef
Appraisal of a Model to Estimate Survival in Ambulatory Patients with Hepatocellular Carcinoma Classified as Barcelona Clinic Liver Cancer Stage B
Jeong-Ju Yoo, Su Jong Yu, Bora Lee, Eun Ju Cho, Jeong-Hoon Lee, Sang Gyune Kim, Yoon Jun Kim, Young Seok Kim, Jung-Hwan Yoon
Gut and Liver.2020; 14(3): 377.     CrossRef
Proposal of a New Risk Score for Patients Treated with Transarterial Chemoembolization due to Recurrent Hepatocellular Carcinoma after Curative Resection: A Multicenter Study
Mi Young Jeon, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Eun Ju Cho, Seung Up Kim
Gut and Liver.2020; 14(4): 477.     CrossRef
Comparison of Transcatheter Arterial Chemoembolization-Radiofrequency Ablation and Transcatheter Arterial Chemoembolization Alone for Advanced Hepatocellular Carcinoma with Macrovascular Invasion Using Propensity Score Analysis: A Retrospective Cohort Stu
Yao Liu, Yuxin Li, Fangyuan Gao, Qun Zhang, Xue Yang, Bingbing Zhu, Shuaishuai Niu, Yunyi Huang, Ying Hu, Wei Li, Xianbo Wang
Journal of Oncology.2020; 2020: 1.     CrossRef
Comparison of outcome between liver resection, radiofrequency ablation, and transarterial therapy for multiple small hepatocellular carcinoma within the Milan criteria
Joo Hyun Oh, Dong Hyun Sinn, Gyu-Seong Choi, Jong Man Kim, Jae-Won Joh, Tae Wook Kang, Dongho Hyun, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik, Moon Seok Choi
Annals of Surgical Treatment and Research.2020; 99(4): 238.     CrossRef
Is Transarterial Chemoembolization Only Treatment Option in Patients with Intermediate Stage of Hepatocellular Carcinoma?: in Perspectives of Surgery
Ji Young Lim, Minjong Lee, Tae Hun Kim
Journal of Liver Cancer.2020; 20(2): 113.     CrossRef
A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients
Zeyu Wang, Ningning Zhang, Jiayu Lv, Cuihua Ma, Jie Gu, Yawei Du, Yibo Qiu, Zhiguang Zhang, Man Li, Yong Jiang, Jianqiu Zhao, Huiqin Du, Zhiwei Zhang, Wei Lu, Yan Zhang, Luca Miele
BioMed Research International.2020; 2020: 1.     CrossRef
Transarterial Chemoembolization Combined With Hepatectomy for the Treatment of Intermediate-Stage Hepatocellular Carcinoma
Qunfang Zhou, Fei Tuo, Ruixia Li, Xiaohui Wang, Juncheng Wang, Zhimei Huang, Minshan Chen, Jinhua Huang
Frontiers in Oncology.2020;[Epub]     CrossRef
The Modified Response Evaluation Criteria in Solid Tumors (RECIST) Yield a More Accurate Prognoses Than the RECIST 1.1 in Hepatocellular Carcinoma Treated with Transarterial Radioembolization
Jae Seung Lee, Hong Jun Choi, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Song-Ee Baek, Yong Eun Chung, Mi-Suk Park, Myeong-Jin Kim, Hyungjin Rhee, Seung Up Kim
Gut and Liver.2020; 14(6): 765.     CrossRef
Comparison between hepatocellular carcinoma prognostic scores: A 10-year single-center experience and brief review of the current literature
Michele Campigotto, Mauro Giuffrè, Anna Colombo, Alessia Visintin, Alessandro Aversano, Martina Budel, Flora Masutti, Cristiana Abazia, Lory Saveria Crocé
World Journal of Hepatology.2020; 12(12): 1239.     CrossRef
Comparison of Partial Hepatectomy and Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Ismail Labgaa, Patrick Taffé, David Martin, Daniel Clerc, Myron Schwartz, Norihiro Kokudo, Alban Denys, Nermin Halkic, Nicolas Demartines, Emmanuel Melloul
Liver Cancer.2020; 9(2): 138.     CrossRef
Refractoriness to transarterial chemoembolization in patients with recurrent hepatocellular carcinoma after curative resection
Mi Young Jeon, Hye Soo Kim, Tae Seop Lim, Dai Hoon Han, Beom Kyung Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Gi Hong Choi, Jin Sub Choi, Kwang-Hyub Han, Seung Up Kim, Gianfranco D. Alpini
PLOS ONE.2019; 14(4): e0214613.     CrossRef
Clinical Relevance of Reductive Hepatectomy for Barcelona Clinic Liver Cancer Stages B and C Advanced Hepatocellular Carcinoma: A Single-Center Experience of 102 Patients
Shohei Komatsu, Masahiro Kido, Motofumi Tanaka, Kaori Kuramitsu, ·Daisuke Tsugawa, Masahide Awazu, Hidetoshi Gon, Hirochika Toyama, Kimihiko Ueno, Takumi Fukumoto
World Journal of Surgery.2019; 43(10): 2571.     CrossRef
Hepatocellular carcinoma staging systems: Hong Kong liver cancer vs Barcelona clinic liver cancer in a Western population
Laura Bainy Rodrigues de Freitas, Larisse Longo, Deivid Santos, Ivana Grivicich, Mário Reis Álvares-da-Silva
World Journal of Hepatology.2019; 11(9): 689.     CrossRef
Surgical resection versus transarterial chemoembolization for BCLC intermediate stage hepatocellular carcinoma: a systematic review and meta-analysis
Lei Liang, Hao Xing, Han Zhang, Jianhong Zhong, Chao Li, Wan Yee Lau, Mengchao Wu, Feng Shen, Tian Yang
HPB.2018; 20(2): 110.     CrossRef
Can More Aggressive Treatment Improve Prognosis in Patients with Hepatocellular Carcinoma? A Direct Comparison of the Hong Kong Liver Cancer and Barcelona Clinic Liver Cancer Algorithms
Young-Sun Lee, Yeon Seok Seo, Ji Hoon Kim, Juneyoung Lee, Hae Rim Kim, Yang Jae Yoo, Tae Suk Kim, Seong Hee Kang, Sang Jun Suh, Moon Kyung Joo, Young Kul Jung, Beom Jae Lee, Hyung Joon Yim, Jong Eun Yeon, Jae Seon Kim, Jong-Jae Park, Soon Ho Um, Young-Tae
Gut and Liver.2018; 12(1): 94.     CrossRef
Chemoembolization related to good survival for selected patients with hepatocellular carcinoma invading segmental portal vein
Jin Hyoung Kim, Ju Hyun Shim, Hyun‐Ki Yoon, Heung‐Kyu Ko, Jong Woo Kim, Dong Il Gwon
Liver International.2018; 38(9): 1646.     CrossRef
Hepatic resection compared to chemoembolization in intermediate- to advanced-stage hepatocellular carcinoma: A meta-analysis of high-quality studies
Myung Han Hyun, Young-Sun Lee, Ji Hoon Kim, Chan Uk Lee, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun
Hepatology.2018; 68(3): 977.     CrossRef
Liver resection versus transarterial chemoembolization for the initial treatment of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma
Biao Yang, Bo Zheng, MaoNan Yang, Zhu Zeng, FangYun Yang, Ji Pu, ChunLin Li, ZhengYin Liao
Hepatology International.2018; 12(5): 417.     CrossRef
Impact of local tumor lesion treatments and preoperative indicators on the survival of patients with small hepatocellular carcinomas
Yanyan Wei, Feng Dai, Yongxiang Yi, Wei Ye, Wei Zhao
Oncology Letters.2018;[Epub]     CrossRef
Outcomes following liver resection for multinodular Barcelona Clinic Liver Cancer‑B hepatocellular carcinoma
Satoshi Matsukuma, Kazuhiko Sakamoto, Yoshihiro Tokuhisa, Yukio Tokumitsu, Hiroto Matsui, Shinsuke Kanekiyo, Shinobu Tomochika, Michihisa Iida, Nobuaki Suzuki, Shigeru Takeda, Tomio Ueno, Hiroshi Wada, Shogo Kobayashi, Issei Saeki, Hidetoshi Eguchi, Masat
Oncology Letters.2018;[Epub]     CrossRef
Therapeutic priorities for solitary large hepatocellular carcinoma in a hepatitis B virus endemic area; an analysis of a nationwide cancer registry database
Young-Joo Jin, Jin-Woo Lee
Journal of Surgical Oncology.2017; 115(4): 407.     CrossRef
Validity of the Barcelona Clinic Liver Cancer and Hong Kong Liver Cancer staging systems for hepatocellular carcinoma in Singapore
Li Kim E. Selby, Rosanna X. Y. Tay, Winston W. L. Woon, Jee Keem Low, Wang Bei, Vishalkumar G. Shelat, Tony C. Y. Pang, Sameer P. Junnarkar
Journal of Hepato-Biliary-Pancreatic Sciences.2017; 24(3): 143.     CrossRef
Survival Analysis of Single Large (>5 cm) Hepatocellular Carcinoma Patients: BCLC A versus B
Yuri Cho, Dong Hyun Sinn, Su Jong Yu, Geum Youn Gwak, Ji Hoon Kim, Yang Jae Yoo, Dae Won Jun, Tae Yeob Kim, Hyo Young Lee, Eun Ju Cho, Jeong-Hoon Lee, Yoon Jun Kim, Jung-Hwan Yoon, Sheng-Nan Lu
PLOS ONE.2016; 11(11): e0165722.     CrossRef